Literature DB >> 17555970

Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.

Tara M Caffrey1, Richard Wade-Martins.   

Abstract

The microtubule-associated protein tau (MAPT) locus has long been associated with sporadic neurodegenerative disease, notably progressive supranuclear palsy and corticobasal degeneration, and more recently with Alzheimer's disease and Parkinson's disease. However, the functional biological mechanisms behind the genetic association have only now started to emerge. The genomic architecture in the region spanning MAPT is highly complex, and includes a approximately 1.8 Mb block of linkage disequilibrium (LD). The region is divided into two major haplotypes, H1 and H2, defined by numerous single nucleotide polymorphisms and a 900 kb inversion which suppresses recombination. Fine mapping of the MAPT region has identified sub-clades of the MAPT H1 haplotype which are specifically associated with neurodegenerative disease. Here we briefly review the role of MAPT in sporadic and familial neurodegenerative disease, and then discuss recent work which, for the first time, proposes functional mechanisms to link MAPT haplotypes with the neuropathology seen in patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555970      PMCID: PMC2801069          DOI: 10.1016/j.nbd.2007.04.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  76 in total

1.  Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing.

Authors:  Christine P Donahue; Christina Muratore; Jane Y Wu; Kenneth S Kosik; Michael S Wolfe
Journal:  J Biol Chem       Date:  2006-06-16       Impact factor: 5.157

2.  Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia.

Authors:  Q S Gao; J Memmott; R Lafyatis; S Stamm; G Screaton; A Andreadis
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

3.  A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity.

Authors:  Lydia Urak; Martha Feucht; Nahid Fathi; Kurt Hornik; Karoline Fuchs
Journal:  Hum Mol Genet       Date:  2006-07-11       Impact factor: 6.150

4.  A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism.

Authors:  David A Koolen; Lisenka E L M Vissers; Rolph Pfundt; Nicole de Leeuw; Samantha J L Knight; Regina Regan; R Frank Kooy; Edwin Reyniers; Corrado Romano; Marco Fichera; Albert Schinzel; Alessandra Baumer; Britt-Marie Anderlid; Jacqueline Schoumans; Nine V Knoers; Ad Geurts van Kessel; Erik A Sistermans; Joris A Veltman; Han G Brunner; Bert B A de Vries
Journal:  Nat Genet       Date:  2006-08-13       Impact factor: 38.330

5.  Haplotype-specific expression of exon 10 at the human MAPT locus.

Authors:  Tara M Caffrey; Catharine Joachim; Silvia Paracchini; Margaret M Esiri; Richard Wade-Martins
Journal:  Hum Mol Genet       Date:  2006-11-03       Impact factor: 6.150

6.  Global variation in copy number in the human genome.

Authors:  Richard Redon; Shumpei Ishikawa; Karen R Fitch; Lars Feuk; George H Perry; T Daniel Andrews; Heike Fiegler; Michael H Shapero; Andrew R Carson; Wenwei Chen; Eun Kyung Cho; Stephanie Dallaire; Jennifer L Freeman; Juan R González; Mònica Gratacòs; Jing Huang; Dimitrios Kalaitzopoulos; Daisuke Komura; Jeffrey R MacDonald; Christian R Marshall; Rui Mei; Lyndal Montgomery; Kunihiro Nishimura; Kohji Okamura; Fan Shen; Martin J Somerville; Joelle Tchinda; Armand Valsesia; Cara Woodwark; Fengtang Yang; Junjun Zhang; Tatiana Zerjal; Jane Zhang; Lluis Armengol; Donald F Conrad; Xavier Estivill; Chris Tyler-Smith; Nigel P Carter; Hiroyuki Aburatani; Charles Lee; Keith W Jones; Stephen W Scherer; Matthew E Hurles
Journal:  Nature       Date:  2006-11-23       Impact factor: 49.962

7.  Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy.

Authors:  E Di Maria; M Tabaton; T Vigo; G Abbruzzese; E Bellone; C Donati; E Frasson; R Marchese; P Montagna; D G Munoz; P P Pramstaller; G Zanusso; F Ajmar; P Mandich
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

8.  Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.

Authors:  M Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; A Grover; J Hackett; J Adamson; S Lincoln; D Dickson; P Davies; R C Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; J C Morris; L A Reed; J Trojanowski; H Basun; L Lannfelt; M Neystat; S Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; D Neary; F Owen; B A Oostra; J Hardy; A Goate; J van Swieten; D Mann; T Lynch; P Heutink
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

9.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

10.  Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability.

Authors:  Charles Shaw-Smith; Alan M Pittman; Lionel Willatt; Howard Martin; Lisa Rickman; Susan Gribble; Rebecca Curley; Sally Cumming; Carolyn Dunn; Dimitrios Kalaitzopoulos; Keith Porter; Elena Prigmore; Ana C V Krepischi-Santos; Monica C Varela; Celia P Koiffmann; Andrew J Lees; Carla Rosenberg; Helen V Firth; Rohan de Silva; Nigel P Carter
Journal:  Nat Genet       Date:  2006-08-13       Impact factor: 38.330

View more
  27 in total

1.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

Review 2.  Tau splicing and the intricacies of dementia.

Authors:  Athena Andreadis
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

3.  Tauopathy-associated PERK alleles are functional hypomorphs that increase neuronal vulnerability to ER stress.

Authors:  Shauna H Yuan; Nobuhiko Hiramatsu; Qing Liu; Xuehan Victoria Sun; David Lenh; Priscilla Chan; Karen Chiang; Edward H Koo; Aimee W Kao; Irene Litvan; Jonathan H Lin
Journal:  Hum Mol Genet       Date:  2018-11-15       Impact factor: 6.150

4.  The cardiotonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B.

Authors:  Erik S Anderson; Chia-Ho Lin; Xinshu Xiao; Peter Stoilov; Christopher B Burge; Douglas L Black
Journal:  RNA       Date:  2012-03-28       Impact factor: 4.942

Review 5.  Frontotemporal dementia: from Mendelian genetics towards genome wide association studies.

Authors:  Raffaele Ferrari; John Hardy; Parastoo Momeni
Journal:  J Mol Neurosci       Date:  2011-09-06       Impact factor: 3.444

6.  Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.

Authors:  Anna P Pilbrow; Kathy A Lewis; Marilyn H Perrin; Wendy E Sweet; Christine S Moravec; W H Wilson Tang; Mark O Huising; Richard W Troughton; Vicky A Cameron
Journal:  Endocrinology       Date:  2016-10-18       Impact factor: 4.736

7.  Unilateral retinitis pigmentosa and cone-rod dystrophy.

Authors:  Donald F Farrell
Journal:  Clin Ophthalmol       Date:  2009-06-02

8.  Physiological transgene regulation and functional complementation of a neurological disease gene deficiency in neurons.

Authors:  Pier Paolo Peruzzi; Sean E Lawler; Steve L Senior; Nina Dmitrieva; Pauline A H Edser; Davide Gianni; E Antonio Chiocca; Richard Wade-Martins
Journal:  Mol Ther       Date:  2009-04-07       Impact factor: 11.454

9.  Splicing factor TRA2B is required for neural progenitor survival.

Authors:  Jacqueline M Roberts; Hanane Ennajdaoui; Carina Edmondson; Brunhilde Wirth; Jeremy R Sanford; Bin Chen
Journal:  J Comp Neurol       Date:  2014-02-01       Impact factor: 3.215

10.  DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.

Authors:  Kirsten G Coupland; George D Mellick; Peter A Silburn; Karen Mather; Nicola J Armstrong; Perminder S Sachdev; Henry Brodaty; Yue Huang; Glenda M Halliday; Marianne Hallupp; Woojin S Kim; Carol Dobson-Stone; John B J Kwok
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.